Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00489476 · ClinicalTrials.gov registry record · Phase 2
Staccato Loxapine in Migraine (in Clinic)
A Phase 2 study, sponsored by Alexza Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 168
- Enrollment target
NCT00489476 is a Phase 2 study that has completed, run by Alexza Pharmaceuticals. The registered enrollment target is 168 participants.
The verdict
NCT00489476, a Phase 2 study, has completed, sponsored by Alexza Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 168 participants
- Enrollment target
Study Summary
The objective of this trial is to assess the efficacy and safety of Staccato Loxapine in patients with migraine headache with or without aura in a clinical setting.
Interventions
- DRUG Staccato Placebo
- DRUG Staccato Loxapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2007-06 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00489476
The ClinicalTrials.gov registry entry for NCT00489476 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alexza Pharmaceuticals, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Staccato Placebo is the first listed.
NCT00489476 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00489476 about?
NCT00489476 is a clinical study titled "Staccato Loxapine in Migraine (in Clinic)". The objective of this trial is to assess the efficacy and safety of Staccato Loxapine in patients with migraine headache with or without aura in a clinical setting.
What is the current status of trial NCT00489476?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 168 participants. The study started on 2007-06. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00489476?
The interventions under investigation include: Staccato Placebo (DRUG), Staccato Loxapine (DRUG).
Who is sponsoring clinical trial NCT00489476?
This trial is sponsored by Alexza Pharmaceuticals, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.